Multiple infections containing the top five prevalent HPV genotypes and their impact on cervical lesions in Changzhou, China

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–7. doi:10.3322/caac.20107.
   PubMed Web of Science ®Google Scholar
• Zhang C, Huang C, Zheng X, Pan D. Prevalence of human papillomavirus among Wenzhou women diagnosed with cervical intraepithelial neoplasia and cervical cancer. Infect Agent Cancer. 2018;13(1):37. doi:10.1186/s13027-018-0211-8.
   PubMedGoogle Scholar
• Zou K, Huang Y, Li Z. Prevention and treatment of human papillomavirus in men benefits both men and women. Front Cell Infect Microbiol. 2022;12:1077651. doi:10.3389/fcimb.2022.1077651.
   PubMed Web of Science ®Google Scholar
• IARC. Monographs on the evaluation of carcinogenic risks to humans. Vol. 90, Human Papillomaviruses; Geneva, Switzerland: WHO; 2007.
   Google Scholar
• Cabibi D, Napolitano C, Giannone AG, Micciulla MC, Porcasi R, Lo Coco R, Bosco L, Vinciguerra M, Capra G. Predictive role of the p16 immunostaining pattern in atypical cervical biopsies with less common high risk HPV genotypes. Diagnostics (Basel). 2021;11(11):1947. doi:10.3390/diagnostics11111947.
   PubMedGoogle Scholar
• Rezaee Azhar I, Yaghoobi M, Mossalaeie MM, Kollaee Darabi A, Nejadeh AH, Jamshidi M, Ahani A, Karkhane Mahmoodi M, Ghalichi L, Shabanzadeh A, et al. Prevalence of human papilloma virus (HPV) genotypes between outpatients males and females referred to seven laboratories in Tehran, Iran. Infect Agent Cancer. 2022;17(1):7. doi:10.1186/s13027-022-00421-7.
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, Muñoz N, Schiffman M, Bosch FX. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine. 2008;26(10):K17–28. doi:10.1016/j.vaccine.2008.06.021.
   PubMed Web of Science ®Google Scholar
• Li K, Li Q, Song L, Wang D, Yin R. The distribution and prevalence of human papillomavirus in women in mainland China. Cancer. 2019 Apr 1;125(7):1030–7. doi:10.1002/cncr.32003.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Katki HA, Hildesheim A, Rodríguez AC, Quint W, Schiffman M, Van Doorn LJ, Porras C, Wacholder S, Gonzalez P, et al. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis. 2011;203(7):910–20. doi: 10.1093/infdis/jiq139.
   PubMed Web of Science ®Google Scholar
• De Brot L, Pellegrini B, Moretti ST, Carraro DM, Soares FA, Rocha RM, Baiocchi G, da Cunha IW, de Andrade VP. Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix. Cancer Cytopathol. 2017;125(2):138–43. doi:10.1002/cncy.21789.
   PubMed Web of Science ®Google Scholar
• Salazar KL, Zhou HS, Xu J, Peterson LE, Schwartz MR, Mody DR, Ge Y. Multiple human papilloma virus infections and their impact on the development of high-risk cervical lesions. Acta Cytol. 2015;59(5):391–8. doi:10.1159/000442512.
   PubMedGoogle Scholar
• Hoppe-Seyler K, Bossler F, Braun JA, Herrmann AL, Hoppe-Seyler F. The HPV E6/E7 oncogenes: key factors for viral carcinogenesis and therapeutic targets. Trends Microbiol. 2018 Feb;26(2):158–68. doi:10.1016/j.tim.2017.07.007.
   PubMed Web of Science ®Google Scholar
• Pal A, Kundu R. Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for therapy. Front Microbiol. 2020;10:3116. doi:10.3389/fmicb.2019.03116.
   PubMed Web of Science ®Google Scholar
• Derbie A, Mekonnen D, Woldeamanuel Y, Van Ostade X, Abebe T. HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review. Infect Agent Cancer. 2020;15:9. doi:10.1186/s13027-020-0278-x.
   PubMed Web of Science ®Google Scholar
• Denis F, Hanz S, Alain S. Clearance, persistence and recurrence of HPV infection. Gynecol Obstet Fertil. 2008;36(4):430–40. doi:10.1016/j.gyobfe.2008.02.008.
   PubMedGoogle Scholar
• Capra G, Giovannelli L, Matranga D, Bellavia C, Guarneri MF, Fasciana T, Scaduto G, Firenze A, Vassiliadis A, Perino A. Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: a referral hospital-based study in Sicily. Hum Vaccin Immunother. 2017;13(8):1839–43. doi:10.1080/21645515.2017.1319026.
   PubMed Web of Science ®Google Scholar
• Dong B, Sun P, Ruan G, Huang W, Mao X, Kang Y, Pan D, Lin F. Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case- control study. Cancer Manag Res. 2018;10:4839–51. doi:10.2147/CMAR.S179724.
   PubMed Web of Science ®Google Scholar
• Andersen B, Njor SH, Jensen AMS, Johansen T, Jeppesen U, Svanholm H. HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study. Int J Gynecol Cancer. 2020;30(11):1678–83. doi:10.1136/ijgc-2020-001457.
   PubMed Web of Science ®Google Scholar
• Asciutto KC, Forslund O, Borgfeldt C. Prevalence of high-risk HPV in postmenopausal women with benign cervical cytology-a population-based cohort study. Anticancer Res. 2018;38(7):4221–8. doi:10.21873/anticanres.12718.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Cai X, Shen F, Ma F. HPV post-infection microenvironment and cervical cancer. Cancer Lett. 2021;497:243–54. doi:10.1016/j.canlet.2020.10.034.
   PubMed Web of Science ®Google Scholar
• Desai S, Zhu MJ, Lapidos-Salaiz I. Cervical cancer prevention: human papillomavirus testing as primary screening. Cancer. 2022;128(5):939–43. doi:10.1002/cncr.34006.
   PubMed Web of Science ®Google Scholar
• Zhang C, Cheng W, Liu Q, Guan Q, Zhang Q. Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province. Virol J. 2019;16(1):67. doi:10.1186/s12985-019-1175-z.
   PubMedGoogle Scholar
• Geng Y, Liu L. Human papillomavirus genotypes and infection among women in Changzhou, China. Hum Vaccin Immunother. 2019;15(7–8):1884–8. doi:10.1080/21645515.2019.1611159.
   PubMed Web of Science ®Google Scholar
• Zang L, Hu Y. Risk factors associated with HPV persistence after conization in high-grade squamous intraepithelial lesion. Arch Gynecol Obstet. 2021;304(6):1409–16. doi:10.1007/s00404-021-06217-1.
   PubMed Web of Science ®Google Scholar
• Zhu X, Wang Y, Lv Z, Su J. Prevalence and genotype distribution of high-risk HPV infection among women in Beijing, China. J Med Virol. 2021;93(8):5103–9. doi:10.1002/jmv.27013.
   PubMed Web of Science ®Google Scholar
• Li M, Du X, Lu M, Zhang W, Sun Z, Li L, Ye M, Fan W, Jiang S, Liu A, et al. Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China. J Med Virol. 2019;91(3):473–81. doi:10.1002/jmv.25331.
   PubMed Web of Science ®Google Scholar
• Xu J, Xia Z, Wang L, Yang B, Zhu Y, Zhu X, Xu L. Human papillomaviruses 16 and 58 are distributed widely among women living in Shanghai, China, with high-grade, squamous intraepithelial lesions. Epidemiol Infect. 2018;147:e42. doi:10.1017/S0950268818003011.
   PubMed Web of Science ®Google Scholar
• Hu Z, Ma D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Med. 2018;7(10):5217–36. doi:10.1002/cam4.1501.
   PubMed Web of Science ®Google Scholar
• Gustinucci D, Giorgi Rossi P, Cesarini E, Broccolini M, Bulletti S, Carlani A, D’angelo V, D’amico MR, Di Dato E, Galeazzi P, et al. Use of cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to define the management of human papillomavirus (HPV)-positive women in cervical cancer screening. Am J Clin Pathol. 2016;145(1):35–45. doi: 10.1093/ajcp/aqv019.
   PubMed Web of Science ®Google Scholar
• Estêvão D, Costa NR, Gil da Costa RM, Medeiros R. Hallmarks of HPV carcinogenesis: the role of E6, E7 and E5 oncoproteins in cellular malignancy. Biochim Biophys Acta Gene Regul Mech. 2019;1862(2):153–62. doi:10.1016/j.bbagrm.2019.01.001.
   PubMed Web of Science ®Google Scholar
• Giorgi Rossi P, Carozzi F, Ronco G, Allia E, Bisanzi S, Gillio-Tos A, De Marco L, Rizzolo R, Gustinucci D, Del Mistro A, et al. p16/ki67 and E6/E7 mRNA accuracy and prognostic Value in triaging HPV DNA-Positive women. J Natl Cancer Inst. 2021;113(3):292–300. doi:10.1093/jnci/djaa105.
   PubMedGoogle Scholar
• Gutiérrez-Hoya A, Soto-Cruz I. Role of the JAK/STAT pathway in cervical cancer: its relationship with HPV E6/E7 oncoproteins. Cells. 2020;9(10):2297. doi:10.3390/cells9102297.
   PubMed Web of Science ®Google Scholar
• Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020 Jul;40(5):602–8. doi:10.1080/01443615.2019.1634030.
   PubMedGoogle Scholar
• World Health Organization. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. PMID: 24716265. Bookshelf ID: NBK195239.
   Google Scholar
• Kim M, Park NJ, Jeong JY, Park JY. Multiple human papilloma virus (HPV) infections are associated with HSIL and persistent HPV infection status in Korean patients. Viruses. 2021;13(7):1342. doi:10.3390/v13071342.
   PubMed Web of Science ®Google Scholar
• Oyervides-Muñoz MA, Pérez-Maya AA, Sánchez-Domínguez CN, Berlanga-Garza A, Antonio-Macedo M, Valdéz-Chapa LD, Cerda-Flores RM, Trevino V, Barrera-Saldaña HA, Garza-Rodríguez ML. Multiple HPV infections and viral load association in persistent cervical lesions in Mexican women. Viruses. 2020;12(4):380. doi:10.3390/v12040380.
   PubMed Web of Science ®Google Scholar
• Della Fera AN, Warburton A, Coursey TL, Khurana S, McBride AA. Persistent human papillomavirus infection. Viruses. 2021;13(2):321. doi:10.3390/v13020321.
   PubMed Web of Science ®Google Scholar
• Jentschke M, Kampers J, Becker J, Sibbertsen P, Hillemanns P. Prophylactic HPV vaccination after conization: a systematic review and meta-analysis. Vaccine. 2020;38(41):6402–9. doi:10.1016/j.vaccine.2020.07.055.
   PubMed Web of Science ®Google Scholar